'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Escherichia coli Infections to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Escherichia coli Infections to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Escherichia coli Infections Therapeutics Clinical Trials 26
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 61
List of Tables
Escherichia coli Infections Therapeutics, Global, Clinical Trials by Region, 2016* 6
Escherichia coli Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Escherichia coli Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Escherichia coli Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Escherichia coli Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Escherichia coli Infections Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Escherichia coli Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Escherichia coli Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
Proportion of Escherichia coli Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
Escherichia coli Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Escherichia coli Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Escherichia coli Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
Escherichia coli Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Escherichia coli Infections Therapeutics, Global, Clinical Trials by Phase, 2016* 19
Escherichia coli Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
Escherichia coli Infections Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Escherichia coli Infections Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Escherichia coli Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Escherichia coli Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
Escherichia coli Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Escherichia coli Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Escherichia coli Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
List of Figures
Escherichia coli Infections Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Escherichia coli Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Escherichia coli Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Escherichia coli Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Escherichia coli Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Escherichia coli Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Escherichia coli Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Escherichia coli Infections Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13
Proportion of Escherichia coli Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
Escherichia coli Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Escherichia coli Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Escherichia coli Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
Escherichia coli Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Escherichia coli Infections Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
Escherichia coli Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
Escherichia coli Infections Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Escherichia coli Infections Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Escherichia coli Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Escherichia coli Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
Escherichia coli Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Escherichia coli Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
Escherichia coli Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 59